IRF4 and familial pancreatic carcinoma: IRF4 downregulation provoked an overall increase in T cell activation in response to antigenlow pancreatic cancer cells reflected by the upregulation of members of the IL-2 signaling pathway, such as CD25 and phospho-STAT5 (48).